Analyze Diet
The Veterinary clinics of North America. Equine practice1999; 15(3); 665-x; doi: 10.1016/s0749-0739(17)30138-4

Equine respiratory pharmacology.

Abstract: Differentiation of diseases of the equine respiratory tract is based on history, clinical signs, auscultation, endoscopy, imaging, and sampling of airway exudate. Upper respiratory therapies include surgical correction of airway obstructions; flushing of localized abscesses (strangles), guttural pouch disease, or sinusitis; and oral or parenteral antibiotic and anti-inflammatory therapy if deemed necessary. Pneumonia usually is treated with antimicrobials, anti-inflammatories, and bronchodilators. Pleural drainage is indicated if significant pleural effusion is present. The most commonly used therapies for early inflammatory and chronic allergic obstructive conditions include bronchodilators and anti-inflammatories. Acute respiratory distress, particularly acute pulmonary edema, is treated with diuretics (usually furosemide), intranasal oxygen, bronchodilators, corticosteroids, and alleviation of the underlying cause. Furosemide also had been used in North America as a race-day preventative for exercise-induced pulmonary hemorrhage (EIPH), but recent data have shown that furosemide may be a performance-enhancing agent itself.
Publication Date: 1999-12-10 PubMed ID: 10589473DOI: 10.1016/s0749-0739(17)30138-4Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper provides an in-depth study of the variety of diseases affecting the equine respiratory tract and their respective treatments. It discusses in detail the use of various forms of therapy, including surgical interventions, pharmaceutical treatments, and respiratory aids, for common equine respiratory diseases.

Understanding Diseases of the Equine Respiratory Tract

  • The differentiation or identification of diseases affecting the equine respiratory tract is achieved through a combination of methods such as patient history, clinical signs, imaging, auscultation (listening to sounds within the body), and endoscopy, which involves using a scope to view the airways, as well as sampling of the secretions (exudate) from the airways.

Therapy for Upper Respiratory Diseases

  • The paper outlines that for diseases affecting the upper respiratory tract, therapeutic measures often include surgical procedures aimed at clearing obstructions, antibiotic and anti-inflammatory treatments administered either orally or parenterally—through routes other than the digestive tract, such as intravenous or intramuscular.
  • In case of specific diseases such as strangles, guttural pouch disease, or sinusitis, localized abscesses are flushed as part of the treatment.

Treatment of Pneumonia and Respiratory Distress

  • For horses suffering from pneumonia, the typical therapeutic protocol includes the use of antimicrobials to fight infection, along with anti-inflammatory drugs and bronchodilators to ease breathing. In situations where significant pleural effusion is observed, pleural drainage is performed.
  • Acute respiratory distress, especially acute pulmonary edema, is usually treated with diuretics such as furosemide, intranasal oxygen to help respiratory efforts, bronchodilators, corticosteroids to reduce inflammation, and efforts to eliminate the underlying cause of the distress.

Allergic Conditions and EIPH

  • For early inflammatory and chronic allergic obstructive conditions, bronchodilators and anti-inflammatories are the most commonly used therapies.
  • Furosemide had been primarily used in North America as a preventative for exercise-induced pulmonary hemorrhage (EIPH), a condition that causes bleeding in the lungs during strenuous exercise. However, recent data suggests that this substance may have performance-enhancing effects in horses, thus raising concerns about its use.

Cite This Article

APA
Foreman JH. (1999). Equine respiratory pharmacology. Vet Clin North Am Equine Pract, 15(3), 665-x. https://doi.org/10.1016/s0749-0739(17)30138-4

Publication

ISSN: 0749-0739
NlmUniqueID: 8511904
Country: United States
Language: English
Volume: 15
Issue: 3
Pages: 665-x

Researcher Affiliations

Foreman, J H
  • Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, USA.

MeSH Terms

  • Animals
  • Anthelmintics / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antifungal Agents / therapeutic use
  • Bronchodilator Agents / therapeutic use
  • Glucocorticoids / therapeutic use
  • Horse Diseases / drug therapy
  • Horses
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / veterinary

References

This article includes 120 references

Citations

This article has been cited 0 times.